SCHEMBL20239677

SCHEMBL20239677

Cc1ccccc1Nc1ccc(Oc2nc(O)c3ccncc3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LATS1 O95835 4/20 0.47
▸ IMPDH2 P12268 1/20 0.39
▸ CCNA2 P20248 1/20 0.39
▸ CDK2 P24941 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ AURKA O14965 1/20 0.39
▸ CSNK2A2 P19784 1/20 0.38
▸ CSNK2B P67870 1/20 0.38
▸ CSNK2A1 P68400 1/20 0.38
▸ KDR P35968 2/20 0.37
▸ ERBB2 P04626 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ PTGS1 P23219 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ PDGFRA P16234 1/20 0.35
▸ SLC2A1 P11166 1/20 0.35
▸ KDM4C Q9H3R0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20801271 0.86 CSNK2A1 (0.44) LATS1CSNK2A2CSNK2BCSNK2A1ERBB2
SCHEMBL17615552 0.85 LATS1 (0.47) LATS1IMPDH2ALDH1A1MAPTKMT2A
SCHEMBL20239673 0.85 LATS1 (0.43) LATS1IMPDH2ALDH1A1MAPTKMT2A
SCHEMBL17615556 0.82 LATS1 (0.49) LATS1IMPDH2MAPTKMT2AAURKA
SCHEMBL17623576 0.81 LATS1 (0.39) LATS1ALDH1A1MAPTSMN1; SMN2CSNK2A2
SCHEMBL17602065 0.81 KDM4C (0.38) LATS1CSNK2A2CSNK2BCSNK2A1KDM4C
SCHEMBL17891438 0.80 KDM4C (0.44) LATS1ALDH1A1SMN1; SMN2KDRKDM4C
SCHEMBL17503825 0.80 KDM4C (0.51) MAPTKMT2ACSNK2A2CSNK2BCSNK2A1
SCHEMBL17602130 0.77 LATS1 (0.47) LATS1CSNK2A2CSNK2BCSNK2A1KDR
SCHEMBL17503810 0.77 SMN1; SMN2 (0.54) ALDH1A1KMT2ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208039-B2 Histone demethylase inhibitors CELGENE QUANTICEL RESEARCH, INC. (US) 2019-02-19 — — US disclosed
US-20180162857-A1 HISTONE DEMETHYLASE INHIBITORS CELGENE QUANTICEL RESEARCH, INC. (US) 2018-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180162857-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM5C, KDM1A LATS1 4187/4885IMPDH2 771/4885CCNA2 2059/4885
US-10208039-B2 Histone demethylase inhibitors KDM1B, KDM5C, KDM1A LATS1 4187/4885IMPDH2 771/4885CCNA2 2059/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback